Gouvernance Biogen Inc.

BIIB

US09062X1037

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:00:00 14/08/2026			Varia. 5j.	Varia. 1 janv.
209,83 ^USD	-0,39%		+0,91%	+19,23%

13/08	Biogen Inc. : Wolfe Research relève son opinion	ZM
11/08	Les géants mondiaux de la pharmacie investissent des milliards pour renforcer leur présence aux États-Unis	RE

Comité Exécutif: Biogen Inc.

Dirigeant

Fonctions occupéesDepuis

Christopher Viehbacher

66 ans

Chief Executive Officer	14/11/2022
President	14/11/2022

Guy Hadari

Chief Tech/Sci/R&D Officer

01/01/2021

Daniel Quirk

Chief Tech/Sci/R&D Officer

28/10/2024

Sean Godbout

51 ans

Comptroller/Controller/Auditor

01/01/2007

Nicole Murphy

53 ans

Chief Operating Officer	01/02/2022
Chief Tech/Sci/R&D Officer	01/02/2022

Jane Grogan

59 ans

Chief Tech/Sci/R&D Officer

02/10/2023

Michael Dambach

59 ans

Treasurer

01/01/2010

Michael Parini

51 ans

General Counsel

03/08/2026

Robin Kramer

60 ans

Director of Finance/CFO

01/03/2025

Ginger Gregory

58 ans

Human Resources Officer

07/07/2017

Timothy Power

Investor Relations Contact

09/12/2024

Wendell C. Taylor

General Counsel	-
Corporate Secretary	-

Composition du Conseil d'Administration: Biogen Inc.

Administrateur

ComitésDepuis

Maria Freire

71 ans

Governance Committee	09/06/2026
Nominating Committee	09/05/2012
Governance Committee Chair
Nominating Committee Chair	05/04/2018
Compensation Committee Chair	09/06/2026

Eric Rowinsky

69 ans

Compensation Committee	01/01/2010
Governance Committee	01/01/2010
Nominating Committee
Nominating Committee Chair

William Hawkins

72 ans

Governance Committee
Nominating Committee	01/09/2020
Audit Committee	19/06/2019

Christopher Viehbacher

66 ans

Governance Committee	01/11/2025
Nominating Committee	01/11/2025
Compensation Committee Chair	01/11/2025

Stephen Sherwin

77 ans

Audit Committee	09/12/2011
Finance Committee	01/01/2010

Mene Pangalos

59 ans

Compensation Committee

Monish Patolawala

56 ans

Audit Committee Chair

01/01/2024

Jesus Mantas

57 ans

Compensation Committee Chair

19/06/2019

Lloyd Minor

68 ans

Audit Committee

Susan Langer

35 ans

Compensation Committee

Dernières Nominations: Biogen Inc.

16/07	Biogen Inc. nomme Michael J. Parini au poste de directeur juridique	CI
04/05	Kyverna Therapeutics, Inc. nomme Nadia Dac au poste de Chief Commercial Officer, à compter du 4 mai 2026	CI
28/04	Immunic, Inc. : changement de Directeur Médical effectif au 24 avril 2026	CI
22/04	Inventiva annonce des changements au sein de sa direction	CI
20/04	Alpha Cognition Inc. annonce des changements au sein de son conseil d'administration	CI
02/04	Bourse : ça bouge chez Stellantis, Renault et Kering, Amazon lorgne Globalstar
24/03	CAMP4 Therapeutics Corporation nomme Michael Maclean à son conseil d'administration	CI

Plus d'Actualités

Anciens Dirigeants et Administrateurs: Biogen Inc.

Insider

Fonctions occupées

DepuisJusqu'au

Susan Alexander

General Counsel	01/01/2006	31/05/2026
Corporate Secretary	01/01/2006	01/03/2017

Richard Mulligan

Director/Board Member	01/06/2009	26/06/2023
Independent Dir/Board Member	01/06/2009	26/06/2023

Alexander Denner

Director/Board Member	04/06/2009	26/06/2023
Independent Dir/Board Member	04/06/2009	26/06/2023

Stelios Papadopoulos

Director/Board Member	01/07/2008	12/06/2014
Chairman	12/06/2014	26/06/2023
Independent Dir/Board Member	12/06/2014	26/06/2023

Brian Posner

Director/Board Member	23/07/2008	15/05/2022
Independent Dir/Board Member	23/07/2008	15/05/2022

Robert W. Pangia

Director/Board Member	01/01/1997	02/06/2021
Independent Dir/Board Member	01/01/1997	02/06/2021

Lynn Schenk

Director/Board Member	01/01/1995	03/06/2020
Independent Dir/Board Member	01/01/1995	03/06/2020

Paul Clancy

Director of Finance/CFO	01/01/2003	13/06/2017
Corporate Officer/Principal	-	-
Sales & Marketing	01/01/2001	01/01/2003

William Young

Director/Board Member	12/11/2003	05/01/2010
Chairman	05/01/2010	12/06/2014
Independent Dir/Board Member	20/07/2011	12/06/2014

Keith Regnante

Public Communications Contact

01/01/1999

01/08/2013

Michael Lytton

Corporate Officer/Principal

30/04/2009

01/02/2011

Eric S. Hoffman

Public Communications Contact	01/01/2006	01/03/2010
Corporate Officer/Principal	01/03/2010	01/01/2011

Robert A. Hamm

Chief Operating Officer	31/03/2009	31/12/2010
Corporate Officer/Principal	01/11/2003	31/03/2009

Elizabeth Woo

Public Communications Contact

01/01/1998

Marijn Dekkers

Director/Board Member

06/06/2007

31/12/2009

Cecil B. Pickett

Chief Tech/Sci/R&D Officer

12/07/2006

12/03/2009

Phillip Sharp

Director/Board Member	01/11/2003	15/07/2009
Founder	01/01/1978	15/07/2009

Alan B. Glassberg

Director/Board Member

01/01/1997

01/06/2009

Hans-Peter Hasler

Chief Operating Officer

01/11/2003

30/03/2009

Faheem Hasnain

Corporate Officer/Principal

01/10/2004

01/09/2008

Alessandra Cesano

Corporate Officer/Principal

01/01/2006

01/01/2008

Alan Belzer

Director/Board Member

01/01/1997

31/05/2007

Mary L. Good

Director/Board Member

01/01/1997

31/05/2007

Arturo Molina

Corporate Officer/Principal

01/07/2003

01/05/2007

Andrew de Guttadauro

Corporate Officer/Principal

01/02/2007

Robert Peach

Corporate Officer/Principal

01/01/2005

Steven Perrin

Corporate Officer/Principal

01/11/2001

01/12/2006

Robert L. de Jager

Chief Tech/Sci/R&D Officer

01/05/2006

01/11/2006

Philip Gotwals

Corporate Officer/Principal

01/08/2004

01/09/2006

Matthew Onaitis

Corporate Officer/Principal

01/01/2006

01/05/2006

Michael LaBarre

Corporate Officer/Principal

01/12/2003

01/04/2006

Katherine J. Turner

Corporate Officer/Principal

01/07/2001

01/11/2005

Michael Gilman

Chief Tech/Sci/R&D Officer	01/05/1999	-
Corporate Officer/Principal	01/03/2012	01/06/2013

Christine Anna White

Chief Tech/Sci/R&D Officer

01/01/1996

01/01/2005

Anne Cook

General Counsel

01/01/1992

01/01/2005

William R. Rohn

Chief Operating Officer

01/11/2003

01/01/2005

Douglas A. Abel

Corporate Officer/Principal

01/08/2000

01/11/2004

Melissa Morandi

Compliance Officer

01/09/2002

01/03/2004

David Hallal

Sales & Marketing

01/08/2002

01/02/2004

Nicolas Barthelemy

Corporate Officer/Principal

01/02/1996

01/02/2004

David Mitchell

General Counsel

01/01/2000

01/01/2004

Pratik Multani

Chief Tech/Sci/R&D Officer

01/01/1999

01/01/2004

Carol Gallagher

Sales & Marketing

01/01/2002

01/11/2003

Thomas F. Keller

Director/Board Member

01/11/2003

Michael D. Kowolenko

Chief Tech/Sci/R&D Officer

01/11/2003

Lawrence C. Best

Director/Board Member

01/11/2003

Jennifer A. Spinella

General Counsel

01/01/2003

Edward Hu

Corporate Officer/Principal

01/04/1998

01/10/2000

Michael Rudolf

Corporate Officer/Principal

01/01/2000

Michael Kauffman

Chief Tech/Sci/R&D Officer

01/09/1995

01/09/1997

John Alam

Corporate Officer/Principal

01/01/1991

01/01/1997

James L. Vincent

Chief Executive Officer	01/01/1985	01/01/1997
Chairman	01/01/1985	01/01/1997

Maurice J. Mezzino

Corporate Officer/Principal

Steven D. Ertel

Corporate Officer/Principal

Randy Maddux

Corporate Officer/Principal

Oscar V. Velastegui

Corporate Officer/Principal

Michael Nourie

Corporate Officer/Principal

Roy Lobb

Corporate Officer/Principal

Steve Johnson

Corporate Officer/Principal

Thomas J. Bucknum

General Counsel

Russell C. Petter

Corporate Officer/Principal

Juswinder Singh

Corporate Officer/Principal

Nabil Hanna

Chief Tech/Sci/R&D Officer

Edgar H. Ulm

Chief Tech/Sci/R&D Officer

Jennifer Neiman

Public Communications Contact

05/06/2009

Raymond G. Arner

General Counsel

Paul Chinn

Corporate Officer/Principal

Richard Hoey

Corporate Officer/Principal

Naomi Aoki

Public Communications Contact

Timothy P. Linkkila

General Counsel

Joe Yacano

Corporate Officer/Principal

Linda M. Robertson

General Counsel

Jack Giese

Corporate Officer/Principal

Paul A. Foster

Corporate Officer/Principal

Katrine Bosley

Corporate Officer/Principal

Emily Bulat

Corporate Officer/Principal

Edward Rodriguez

Comptroller/Controller/Auditor

C. Eric Schwartz

Corporate Officer/Principal

Gary Payton

Corporate Officer/Principal

Tanji Goodfellow

Corporate Officer/Principal

Steven Chartier

Corporate Officer/Principal

David N. Cordo

Corporate Officer/Principal

Amy Cohen

Corporate Officer/Principal

Kjell Rensfeldt

Corporate Officer/Principal

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	23
Femme	6

Dont comité exécutif

Homme	10
Femme	2

Dont Administrateurs

Homme	9
Femme	1

Révisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Non

Controverses sur les droits de l'Homme

Non

Controverses Subventions fiscales

Non

Conforme à la finance Islamique

Biogen Inc. figure parmi les leaders mondiaux de la conception, de la fabrication et de la commercialisation de produits thérapeutiques. Le CA par source de revenus se répartit comme suit : - ventes de médicaments (72%) : destinés au traitement de la sclérose en plaques, du psoriasis chronique chez l'adulte, de la polyarthrite rhumatoïde, des cancers, etc. ; - royalties (7,4%) ; - autres (20,6%) : notamment revenus issus d'accords de partenariats.

Employés

7 500

Secteur

Produits pharmaceutiques

Plus d'informations sur la société